文献速递产科母胎医学

子痫前期预防中阿司匹林依从性评估及不依从原因分析

Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence.
PubMed 文献 · Am J Obstet Gynecol MFM · 2022-05-14

本研究采用匿名书面调查,评估符合美国妇产科医师学会(ACOG)标准的子痫前期高危孕妇是否 recalled 阿司匹林推荐及依从性相关因素。共发放544份问卷,回收500份(回收率91.9%)。104例高危妊娠中60例(57.7%)被推荐阿司匹林;269例有2个及以上中危因素者中仅13例(4.8%)被推荐。recalled 推荐者中高危组依从率81.7%,中危组76.9%(P=.69)。

要点

  • 高危妊娠中仅57.7%被推荐阿司匹林,中危因素≥2个者仅4.8%被推荐。
  • recalled 推荐者依从率高危组81.7% vs 中危组76.9%,无显著差异(P=.69)。
  • 不依从者极少与医生讨论决定(5.9%)。

核心结论

  • 在所研究人群中,许多符合ACOG标准的高危患者未 recalled 阿司匹林预防子痫前期的推荐,提示咨询缺失或无效。
  • recalled 推荐的患者中多数报告依从,高血压病史或子痫前期史、自身免疫病和孕前糖尿病最常与依从相关。
  • 无单一因素最强地与有意不依从相关。

研究设计与样本

  • 匿名书面调查研究,发放544份问卷,回收500份(回收率91.9%)。
  • 根据ACOG指南将参与者分为高危、中危或低危。
  • 评估自我报告的依从性及影响患者决定服用或拒绝阿司匹林的因素。

主要发现

  • 104例高危妊娠中,60例被推荐阿司匹林(57.7%;95%CI 0.48-0.67)。
  • 269例有2个及以上中危因素者中,13例被推荐阿司匹林(4.8%;95%CI 0.03-0.08)。
  • recalled 推荐者中,高危组依从率81.7%,中危组76.9%(P=.69)。
  • 慢性高血压、既往妊娠子痫前期或妊娠期高血压史、孕前糖尿病患者最常报告接受阿司匹林推荐(分别为78.8%、76.5%、63.8%和53.3%)。
  • 42.3%的高危参与者未 recalled 阿司匹林推荐,其中自身免疫病、多胎妊娠和肾脏疾病为最常见风险因素(分别为42.9%、35.7%和25.0%)。

关键数值与推荐

  • ACOG推荐高危患者每日低剂量阿司匹林,理想情况下在妊娠16周前开始,以降低子痫前期风险。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Preeclampsia is a hypertensive disease unique to pregnancy and has a significant impact on maternal and neonatal morbidity and mortality. Daily aspirin has been demonstrated to reduce the risk of preeclampsia. The American College of Obstetricians and Gynecologists recommends daily low-dose aspirin, ideally before 16 weeks' gestation, in at-risk patients for preeclampsia risk reduction. This study examined whether patients at-risk for preeclampsia by the American College of Obstetricians and Gynecologists criteria recalled aspirin recommendation and factors associated with treatment adherence. OBJECTIVE: This study examined whether patients at-risk for preeclampsia by the American College of Obstetricians and Gynecologists criteria recalled aspirin recommendation and factors associated with treatment adherence. STUDY DESIGN: This study used an anonymous written survey. Pregnant patients were asked to record self-reported risk factors and to recall recommendation to take aspirin for preeclampsia prophylaxis. Participants were then determined to be high-, moderate-, or low-risk on the basis of the American College of Obstetricians and Gynecologists guidelines. Self-reported adherence to recommendations and factors contributing to the patients' decisions to take or decline aspirin were assessed. Secondary outcomes included demographic characteristics of adherent patients and patients who did not recall aspirin recommendation. RESULTS: A total of 544 surveys were distributed and 500 were returned (91.9% response rate). Of the 104 high-risk pregnancies identified, aspirin was recommended in 60 (57.7%; 95% confidence interval, 0.48-0.67). Of the 269 patients with 2 or more moderate-risk factors, aspirin was recommended for 13 (4.8%; 95% confidence interval, 0.03-0.08). Among the participants who recalled aspirin recommendation, adherence was similar between high-risk (81.7%) and moderate-risk (76.9%) groups (P=.69). Patients with chronic hypertension, a history of preeclampsia or gestational hypertension in a previous pregnancy, and pregestational diabetes mellitus were most likely to report receiving aspirin recommendation (78.8%, 76.5%, 63.8%, and 53.3%, respectively). No high-risk factor was associated with a decreased likelihood of adherence. Nonadherent patients rarely discussed their decision with their medical provider (5.9%). In the 42.3% of high-risk participants who did not recall aspirin recommendation, autoimmune disease, multiple gestation, and kidney disease were the most prevalent risk factors (42.9%, 35.7%, and 25.0%, respectively). CONCLUSION: In the population studied, many at-risk patients, as defined by the American College of Obstetricians and Gynecologists criteria, did not recall recommendations to take aspirin for preeclampsia prophylaxis. This raises concerns for absent or ineffective counseling. Of the patients who recalled aspirin recommendation, most reported adherence, and a history of hypertensive disorders or preeclampsia, autoimmune disease, and pregestational diabetes mellitus were most often associated with adherence. There was no single factor most strongly associated with intentional nonadherence.

来源:Am J Obstet Gynecol MFM,查看原文。版权归原作者所有。

引用

  1. Olson DN, Russell T, Ranzini AC, et al. Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence. Am J Obstet Gynecol MFM. 2022. PMID: 35580761. doi:10.1016/j.ajogmf.2022.100663

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。